Kastenhuber Edward R, Johnson Jared L, Yaron Tomer M, Mercadante Marisa, Cantley Lewis C
Meyer Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Dana Farber Cancer Institute, Boston, MA, USA.
bioRxiv. 2022 Jun 16:2022.06.16.496428. doi: 10.1101/2022.06.16.496428.
Previously, we showed that coagulation factors directly cleave SARS-CoV-2 spike and promote viral entry (Kastenhuber et al., 2022). Here, we show that substitutions in the S1/S2 cleavage site observed in SARS-CoV-2 variants of concern (VOCs) exhibit divergent interactions with host proteases, including factor Xa and furin. Nafamostat remains effective to block coagulation factor-mediated cleavage of variant spike sequences. Furthermore, host protease usage has likely been a selection pressure throughout coronavirus evolution, and we observe convergence of distantly related coronaviruses to attain common host protease interactions, including coagulation factors. Interpretation of genomic surveillance of emerging SARS-CoV-2 variants and future zoonotic spillover is supported by functional characterization of recurrent emerging features.
此前,我们发现凝血因子可直接切割严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白并促进病毒进入(卡斯滕胡伯等人,2022年)。在此,我们表明,在关注的SARS-CoV-2变异株(VOCs)中观察到的S1/S2切割位点的替换与宿主蛋白酶(包括凝血因子Xa和弗林蛋白酶)表现出不同的相互作用。那法莫司他仍然能够有效地阻断凝血因子介导的变异刺突序列切割。此外,在整个冠状病毒进化过程中,宿主蛋白酶的使用可能一直是一种选择压力,并且我们观察到远缘相关冠状病毒趋同以获得共同的宿主蛋白酶相互作用,包括凝血因子。对新出现的SARS-CoV-2变异株的基因组监测以及未来人畜共患病外溢的解读得到了反复出现的新特征的功能表征的支持。